Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB
about
MDMA for the treatment of mood disorder: all talk no substance?Toxicity of amphetamines: an updateImaging the serotonin transporter during major depressive disorder and antidepressant treatmentThe effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesVerbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.Ecstasy exposure & gender: examining components of verbal memory functioningSerotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy useNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineSerotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy.Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in ratsDecreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Amphetamine toxicities: classical and emerging mechanisms.5-HT radioligands for human brain imaging with PET and SPECTMDMA administration decreases serotonin but not N-acetylaspartate in the rat brainLow striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug usersHuman Ecstasy use is associated with increased cortical excitability: an fMRI study.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats.First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyMitochondria: key players in the neurotoxic effects of amphetamines.Recent progress of imaging agents for Parkinson's disease.N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907"Ecstasy" toxicity to adolescent rats following an acute low binge doseReinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug usersEffects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.A clinical crossroads for MDMA.A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers.Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing
P2860
Q21558551-F560A6F1-646A-49C5-8880-F24980EE8BDAQ22252794-ADDDD38B-0CF9-4948-856A-19985C86EF19Q24683135-C879CB89-1EE1-4620-AA29-5D36FF35A6FAQ28069364-DACAE2C4-F543-435F-AEF8-A438E1A1BD0CQ28486090-0AF50450-5358-4503-9C49-9207A4769326Q28542888-5E5F8ACD-1172-4140-B72B-AA8C5F6B727DQ29473848-57CCF573-AF76-453A-9AB5-838F7A5EFA40Q30417935-BD6A19E0-5D36-46F1-A4E3-CB4D15833909Q30663345-4852AC82-4FBC-481C-B392-9481262702D0Q31033312-9E1ADE4E-1A0D-47C0-B617-FE4FC83B3B45Q33586450-D92765FA-8613-40AA-A3E1-72C9ED3E0D1BQ33637117-F968EAC7-3CCB-4B51-9222-1AADFEAD4FC5Q33835470-5A11871B-01AE-46DA-BF0B-E6B1C989203AQ34030711-C906BEAF-5D30-47E6-B329-732306FBB8CEQ34102002-B4FCD201-D120-4815-8442-E8B3992658F3Q34192729-9EC8C7E2-FC44-40BD-9FDF-15ACE681E208Q34280047-FE3C422B-CB20-40AE-AF11-7A53115B687DQ34597927-CC0998A5-AE43-403A-A64F-021FB212718AQ34618285-7E59C242-B574-4F27-BE42-796EABD9B5D7Q34634128-25CDD136-5D61-45CC-B610-3CDD79BC97BDQ34820201-DC0A2E41-691A-46D8-8032-2C3F21C8DED5Q35010538-245A3834-AF97-4EF2-951D-3096F7AE9661Q35017128-C5972111-0203-47B2-AE59-0C80D1CBA20DQ35077922-34CC13CD-0CA7-4DF7-878F-157F1F02ACB0Q35078880-388FD971-11CB-4A4F-9543-4B5100F8AE80Q35141323-A482FE60-B298-43BB-A9CE-7D6CD81D89F0Q35415158-CF340455-6BBB-4D55-B1A4-4E282707400EQ35572468-B30E4D3D-D5EF-4D24-857A-2C89942F1C12Q35595426-FE1E8A01-5CFB-4DF9-9BCF-54166B2E52B2Q35671537-F1BC6B7F-7EF5-4E24-B0CB-44F65C9C2131Q35854864-6C75DEF5-6670-40D8-ADCC-7FA576F3B002Q35892741-F2F5C7BB-FE6D-414B-A0A4-01C5C2E83007Q36062756-F10B552C-115C-4225-9499-1222B36D8868Q36123239-F8FFFAE6-635B-4A1C-8745-0F0E66FD81F0Q36255067-85CF050C-EB11-446C-B91A-08CFF33FE013Q36312733-4D56AF09-72BB-445B-92D7-ED5E1EE9F1B3Q36397237-867CEF8D-EB9B-469D-B714-F4747343BDA5Q36410788-AB5CDFC1-D29C-462B-9DA9-E6634E1DA0B0Q36515912-4548A2FF-901C-417C-ADF6-34ED5AFC09C6Q36736116-441EAF88-12FC-4365-A2F3-059F75CF6150
P2860
Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@ast
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@en
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@nl
type
label
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@ast
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@en
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@nl
prefLabel
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@ast
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@en
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@nl
P2093
P2860
P3181
P356
P1476
Quantitative PET studies of th ...... ing [11C]McN5652 and [11C]DASB
@en
P2093
Esen Seckin
George A Ricaurte
Hayden T Ravert
Peter Rosenblatt
Robert F Dannals
Una D McCann
William B Mathews
Zsolt Szabo
P2860
P2888
P304
P3181
P356
10.1038/SJ.NPP.1300736
P407
P577
2005-09-01T00:00:00Z
P5875
P6179
1027407508